Free Trial

Schrödinger Q4 2023 Earnings Report

Schrödinger logo
$19.96 -0.30 (-1.48%)
As of 04:00 PM Eastern

Schrödinger EPS Results

Actual EPS
-$0.32
Consensus EPS
-$0.44
Beat/Miss
Beat by +$0.12
One Year Ago EPS
-$0.39

Schrödinger Revenue Results

Actual Revenue
$74.10 million
Expected Revenue
$79.12 million
Beat/Miss
Missed by -$5.02 million
YoY Revenue Growth
+30.50%

Schrödinger Announcement Details

Quarter
Q4 2023
Time
After Market Closes

Conference Call Resources

Remove Ads

Schrödinger Earnings Headlines

Partner with Elon Musk on Project Colossus… Before May 1st
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
See More Schrödinger Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Schrödinger? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Schrödinger and other key companies, straight to your email.

About Schrödinger

Schrödinger (NASDAQ:SDGR), together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

View Schrödinger Profile

More Earnings Resources from MarketBeat